HIV Prevention and Alcohol (R34 Clinical Trials Optional)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity focuses on enhancing HIV/AIDS prevention strategies for populations affected by alcohol use. It aims to integrate effective interventions while promoting research that can help decrease new infections. The R34 funding is intended for studies that will guide the planning of a clinical trial related to HIV prevention and alcohol. Applicants should show that their research is necessary to design or plan the future trial. The supported research should yield results that in…
The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with…
Source
Grant ID
PAS-23-172
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Program
SBIR
Key Dates
Opportunity Released
May 12, 2023
Open for Submission
May 12, 2023
Submission Deadline
May 7, 2026
Application Window Closes
May 7, 2026
Similar opportunities
- HIV Prevention and Alcohol (R34 Clinical Trials Optional)
- HIV Prevention and Alcohol (R01 Clinical Trials Optional)
- Notice of Funding Opportunity for Research at the Intersection of HIV and Substance Use
- Notice of Funding Opportunity for Research on Interventions for People Who Use Drugs
- HIV Prevention and Alcohol (R01 Clinical Trials Optional)